Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice  by Fan, Guoping et al.
Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and
neonatal respiratory distress in mice
Guoping Fana;1, Lei Xiaob;1, Lu Chengb, Xinhui Wangc, Bo Sund, Gengxi Hub;*
aWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
bMax-Planck Guest Laboratory, Shanghai Institute of Cell Biology, Chinese Academy of Science, 320 Yueyang Road, Shanghai 200031, PR China
cSchool of Life Sciences, University of Science and Technology of China, Hefei 230027, PR China
dChildren’s Hospital Research Institute, Shanghai Medical University, Shanghai 200032, PR China
Received 20 December 1999
Edited by Jesus Avila
Abstract In order to address the biological function of GlcNAc
N-deacetylase/N-sulfotransferase-1 (NDST-1), we disrupted the
NDST-1 gene by homologous recombination in mouse embryonic
stem cells. The NDST-1 null mice developed respiratory distress
and atelectasis that subsequently caused neonatal death.
Morphological examination revealed type II pneumocyte im-
maturity, which was characterized by an increased glycogen
content and a reduced number of lamellar bodies and microvilli.
Biochemical analysis further indicated that both total phospho-
lipids and disaturated phosphatidylcholine were reduced in the
mutant lung. Our data revealed that NDST-1 was essential for
the maturation of type II pneumocytes and its inactivation led to
a neonatal respiratory distress syndrome.
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1. Introduction
Heparan sulfate proteoglycans (HSPGs) are macromole-
cules associated with the cell surface and the extracellular
matrix where they regulate cell adhesion, growth, migration,
di¡erentiation and gene expression. They are composed of a
core protein and the negatively charged heparan sulfate gly-
cosaminoglycan side chain, which is covalently bound to the
core protein (reviewed in [1]). The modi¢cations of the glyco-
saminoglycan chains are catalyzed by various enzymes while
GlcNAc N-deacetylation/N-sulfation are prerequisites for all
of the other modi¢cations and are catalyzed by a single-
chain polypeptide GlcNAc N-deacetylase/N-sulfotransferase
(NDST) [2]. Three di¡erent isozymes with high sequence sim-
ilarity have been identi¢ed and named NDST-1, NDST-2,
and NDST-3 [2^5]. The NDST-2-de¢cient mice are unable
to synthesize sulfated heparin and show abnormal mast cells
[6,7].
2. Materials and methods
2.1. Construction of the targeting vector
A murine NDST-1 genomic DNA fragment was acquired by screen-
ing a 129/sv genomic library (kindly provided by Dr. En Li). A Hin-
dIII fragment and an EcoRI fragment were subcloned into plasmid
pBluescript II KS. The precise structure of the ¢rst exon was deter-
mined by sequencing. The pgk-neo-polyA cassette was released from
vector with EcoRI and HindIII, ¢lled in with Klenow enzyme, and
cloned into the blunt-ended BspEI site of the NDST-1 gene’s ¢rst
exon at 19 bp downstream of the ATG site and an EcoRI site was
re-created.
2.2. Transfection and selection of embryonic stem (ES) cells
The linearized targeting vector was electroporated into J1 ES cells
(a kind gift from Dr. En Li) and clones that had survived selection in
G418 were Southern-blotted using a HindIII fragment £anked the
targeting vector (Fig. 1) according to Li et al. [8].
2.3. Generation of chimeras and NDST-1 null mutant
Chimeras were generated as described by Bradley [9]. Two ES cell
clones that had undergone homologous recombination were injected
into C57BL/6 blastocysts. Resultant chimeras were crossed with
C57BL/6 and agouti F1 progeny were screened by tail biopsy. By
intercrossing heterozygous mice, NDST-1-de¢cient mice were ac-
quired. F2 progeny were genotyped by PCR. Ampli¢cation was per-
formed for 35 cycles at 94‡C, 30 s, 65‡C, 30 s and 72‡C, 5 min. The
regions of the primers (p1: GGTCT TGGAA TTGTG CAGTG TC;
p2: GTGCT TTACG GTATC GCCGC TC; p3: GCCAT TAGCT
GAACA TCCTG ACC) are indicated in Fig. 1A.
2.4. Histology and transmission electron microscopy
Newborn mice were pre¢xed transcardially with 4% paraformalde-
hyde in 0.1 M phosphate bu¡er (pH 7.4). Tissues were dehydrated in
a series of alcohol steps, transferred into xylene and embedded in
para⁄n. Hematoxylin-eosin staining was performed. For electron mi-
croscopy (EM), the lungs were ¢xed overnight in 2% glutaraldehyde,
washed in phosphate-bu¡ered saline, dehydrated in a series of ethanol
steps, and processed for EM using routine procedures.
2.5. Alveolar surfactant analysis
Lung tissues were homogenized in 0.85% saline and the amount of
disaturated phosphatidylcholine (DSPC) was measured by extracting
an aliquot with chloroform/methanol (2:1), followed by treatment of
the lipid extract with OsO4 in carbon tetrachloride and alumina col-
umn chromatography according to Mason et al. [10]. Total phospho-
lipids (TPL) were determined as described by Bartlett [11]. The con-
centration was expressed as mg/g wet lung.
3. Results
To investigate the function of NDST-1, we used homolo-
gous recombination to disrupt the NDST-1 gene in mice. The
targeting construct is illustrated in Fig. 1. Two ES cell clones
which underwent homologous recombination were injected
into C57BL/6 blastocysts, From these NDST-1(+/3) and
NDST-1(3/3) mice were generated. The phenotypes were an-
alyzed using F2 littermates on outbred genetic background.
Homozygote F2 o¡spring mice with homozygous null al-
leles for NDST-1 (n = 41) derived from the intercross of het-
erozygous animals died in the neonatal period (range 5 min^
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Fig. 1. Targeted disruption of the mouse NDST-1 gene. A: Structure of the wild type NDST-1 gene, the targeting vector and the mutated lo-
cus. Open box: ¢rst translated exon. B, BspEI; E, EcoRI; H, HindIII. B: Genotyping of ES cells and F1 o¡spring mice by Southern blot. The
NDST-1 genotype is indicated. C: Genotyping of F2 progeny by PCR. The PCR products are indicated in A.
Fig. 2. Appearance of newborn mice and their lungs. A: Shortly after birth (about 5 min) a control mouse (left) appears pink while a 3/3
mouse (right) appears cyanotic with breathing di⁄culty. B: Neonatal lungs of a control mouse (left) and a NDST-1(3/3) mouse (right). Lungs
of control mice appear pink and those of 3/3 mice appear red and liver-like. C: NDST-1(3/3) lungs (the lower one) have sunk while the con-
trol lungs are £oating in the water.
FEBS 23259 28-1-00 Cyaan Magenta Geel Zwart
G. Fan et al./FEBS Letters 467 (2000) 7^118
10 h). The null mice experienced severe respiratory di⁄culties
as judged from their gasping breath and cyanotic skin color
(Fig. 2A). Autopsy of NDST-1(3/3) mice revealed no visible
developmental defects other than abnormal development of
the lung that appeared red in color, liver-like (Fig. 2B) and
airless (Fig. 2C). Histological examination demonstrated that
NDST-1(3/3) lungs have normal branching morphology but
exhibit atelectasis and thicker alveolar septa compared with
those of control [NDST-1(+/+) and NDST-1(+/3)] littermates
(Fig. 3).
Morphological examination by EM revealed that the type
II pneumocytes of NDST-1(3/3) lungs had glycogen accumu-
lations, reduced numbers of lamellar bodies and attenuated
microvilli compared with control mice (Fig. 4). These pheno-
Fig. 3. Histology of the neonatal lungs. After 10 min spontaneous breathing, control lungs (A) aerated alveolar spaces, while NDST-1(3/3)
lungs (B) showed severe atelectasis of the alveolar spaces. Scale bar: 140 Wm.
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types are representative for immaturity of the type II pneumo-
cytes in the homozygous null-allele mice. It is well known that
at a late stage of fetal development, mammalian alveolar epi-
thelia di¡erentiate abruptly for postnatal adaptation. Some of
the most signi¢cant changes occur in type II pneumocytes,
such as the disappearance of glycogen and the generation of
microvilli and lamellated inclusion granules, which contain
pulmonary surfactant. Premature birth before adequate type
II cell maturation could be associated with neonatal respira-
tory distress syndrome (RDS), which is often fatal [12]. In our
observation, neonatal NDST-1(3/3) mice experienced devel-
opmental arrest of the type II pneumocytes, which was con-
sistent with clinical and pathological features of RDS [12].
Since the type II pneumocytes of lungs are the site of syn-
thesis, storage, secretion, and recycling of the pulmonary sur-
factant, which is essential for lowering surface tension at the
air^liquid interface [13], it is likely that the immature lungs
from the homozygous null-allele mice lack surfactant. We
therefore measured the contents of DSPC and TPL in the
whole lung tissue. We observed that in the null mice both
DSPC and TPL decreased 33.2% (n1 = 8, n2 = 4, P6 0.01)
and 24.4% (n1 = 8, n2 = 4, P6 0.05) respectively compared to
the controls (Fig. 5). Taken together, our data indicated that
the neonatal death of the NDST-1 null mice is due to imma-
turity of type II pneumocytes that further leads to insu⁄cient
production of surface tension-lowering pulmonary surfactant
and NDST-1 is essential for the maturation of type II pneu-
mocytes during pulmonary development.
4. Discussion
We demonstrated that mice null for NDST-1 developed
immaturity of type II pneumocytes. As a consequence they
died shortly after birth. The development of other organs,
however, showed no pathological defects suggesting that
NDST-1 played a non-redundant role in the di¡erentiation
of type II pneumocytes. We propose two models to explain
this phenotype. NDST-1 may be required for the modi¢cation
of subtype heparin sulfate glycosaminoglycan (HS GAG)
which is necessary for the di¡erentiation of type II pneumo-
cytes; alternatively, reduction of sulfation in NDST-1 null
mice may quantitatively reduce the gross amount of HS
GAG that is required for multiple signaling processes during
lung development.
The development of the respiratory system requires epithe-
lial^mesenchymal interaction mediated by speci¢c ¢broblast
growth factor ligand^receptor signaling as well as modulation
by other peptide growth factors including epidermal growth
factor, platelet-derived growth factor A and transforming
growth factor L and by extracellular matrix components (re-
viewed in [14]). HSPGs can function as coreceptors for all
these growth factors through several mechanisms, including
facilitating or stabilizing ligand^ligand dimerization and sub-
sequent ligand^receptor interaction as well as altering their
e¡ective concentration [15^20]. The speci¢city of HSPG^li-
gand interactions resides, at least in part, in the structure of
Fig. 4. Electron microscopy analysis. NDST-1(3/3) alveolar epithelial cells (B) contained more glycogen (*) and fewer lamellar bodies (arrow-
head) than cells of control (A). Scale bar: 3.5 Wm.
Fig. 5. Phospholipid analysis. DSPC decreased by 33.2% (n1 = 8,
n2 = 4, P6 0.01) and TPL decreased by 24.4% (n1 = 8, n2 = 4,
P6 0.05) compared to control. Values are mean þ S.E.M.
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the HS GAG side chains that vary in number, length, se-
quence composition, and sulfation pattern between di¡erent
cell types and di¡erent developmental stages [21]. NDST-1
may be required for the modi¢cation of a lung-speci¢c HS
GAG that is necessary for signaling activity of a speci¢c sig-
naling molecule. Disruption of NDST-1 may result in defects
of a lung-speci¢c HS GAG necessary for signaling of a spe-
ci¢c signaling molecule. This may further lead to immaturity
of type II pneumocytes, or may quantitatively reduce the ac-
tivities of several growth factors with the consequence of type
II cell developmental arrest. Future experiments determining
the signaling activity a¡ected will be necessary to address this
issue.
The speci¢c lung defect observed in NDST-1 raised a very
interesting issue about the tissue-speci¢c function of individ-
ual members of the NDST protein family. Our results support
the hypothesis that individual members of the NDST protein
family may be required for the modi¢cation of subtype HS
GAG that is required for speci¢c cellular functions during
development. Interestingly, and consistent with our hypothe-
sis, mice with homozygous null alleles for NDST-2 develop
only abnormal mast cells and are unable to synthesize sulfated
heparin, suggesting that NDST-2 is crucial for heparin bio-
synthesis in mast cells as proposed by Forsberg et al. [6,7].
Considering the gene’s widespread expression [2,5], it is inter-
esting that other organs appear to develop normally in the
mutant. Although it is possible that NDST-1 is only required
in the developing lung, it is more likely that in other tissues
and organs the function of NDST-1 can be compensated for
by other members of the NDST family. Examination of mice
null for both NDST-1 and other NDST family members will
be able to address these issues.
Our results demonstrated that NDST-1 null mice develop
lung defects that resemble neonatal RDS in humans [12], and
thus provide a valuable genetic model for studying the disease.
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